Transdermal nitroglycerin patches show potential for managing menopausal hot flashes - News-Medical

Review finds ADHD drugs may ease perimenopause brain fog and improve daily focus, but objective cognition gains remain unclear; larger safety and efficacy studies needed. According to a new review, attention-deficit/hyperactivity disorder (ADHD) medications may help improve brain fog in perimenopausal women. Investigators underwent a scoping review to better understand the potential of ADHD medications as a novel, targeted therapy to improve executive dysfunction experienced during women’s perimenopause period. They specifically looked at original research studies involving the ADHD medications lisdexamfetamine and atomoxetine, and their effects on cognition and ADHD symptom severity. Inclusion criteria included biological women 45 to 60 years of age with a last menstrual period less than 10 years ago. Exclusion criteria included transgender women, disordered sleep, surgical menopause, primary ovarian insufficiency, premature or early menopause, and previous or current cancer diagnosis. “Many women at perimenopause notice changes in focus, memory, and organization that look a lot like ADHD, and the two can be hard to tell apart.

The American College of Physicians published a clinical guideline featuring recommendations for the treatment of women with menopausal vasomotor symptoms. HealthDay News — Recommendations are presented for the treatment of women with menopausal vasomotor symptoms in a clinical guideline issued by the American College of Physicians and published online Oct. 6 in the Annals of Internal Medicine.

More attention than ever is being paid today to midlife women's health, including the menopause transition. However, a new scoping review reveals that ongoing inconsistencies and gaps in documentation of symptoms, menopause status, and reproductive stage in electronic health record (EHR) systems are preventing consistent quality care, research analysis, and positive health outcomes. Scoping review results are published online today in Menopause, the journal of The Menopause Society. Approximately 1.3 million US women enter the menopause transition each year, with an estimated 1.1 billion women globally classified as postmenopausal. Although menopause is a normal life stage, it is associated with a wide range of symptoms and long-term health consequences affecting cardiovascular, musculoskeletal, neurologic, and mental health systems. Common symptoms, including hot flashes, sleep disturbances, mood changes, joint pain, and genitourinary symptoms, are frequently reported but are often inconsistently documented in clinical records.

Hang Liu1, Peng Liu3, Jiawei Yu1, Qiang Lu2, Yerong Qian1, Junxi Xiang1, Aihua Shi4, Shasha Wei4, Yi Lv1,3,4 & … Lifei Yang3,4 We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

David Mannino | Professor, University of Kentucky College of Medicine, Lexington, USA; Chief Medical Officer, COPD Foundation Could you tell us what first drew you to respiratory medicine and COPD, and how this interest has developed throughout your career?